Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (90)

2021

  1. CRC: A Darwinian model of cellular immunoselection

    Foundations of Colorectal Cancer (Elsevier), pp. 529-541

  2. Tumor escape phenotype in bladder cancer is associated with loss of HLA class I expression, T-cell exclusion and stromal changes

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2018

  1. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

    Immunogenetics, Vol. 70, Núm. 10, pp. 647-659

  2. HLA class I loss and PD-L1 expression in lung cancer: Impact on T-cell infiltration and immune escape

    Oncotarget, Vol. 9, Núm. 3, pp. 4120-4133

2017

  1. Surgical treatment of low and intermediate grade lung net

    Journal of Thoracic Disease, Vol. 9, pp. S1435-S1441

2016

  1. Leiomioma de esófago con intensa captación de 18fluorodeoxiglucosa en la tomografía por emisión de positrones-tomografía computarizada

    Cirugia Espanola, Vol. 94, Núm. 7, pp. 419-422

2015

  1. Colorectal cancer classification and cell heterogeneity: A systems oncology approach

    International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 13610-13632

2014

  1. Atypical carcinoid tumours of the lung: Prognostic factors and patterns of recurrence

    Thorax, Vol. 69, Núm. 7, pp. 648-653

  2. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

    BMC Cancer, Vol. 14, Núm. 1

  3. Hemangioma de esófago cervical

    Cirugia Espanola

2013

  1. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes

    Pathobiology, Vol. 80, Núm. 1, pp. 32-40

  2. Immune in filtrates are prognostic factors in localized gastrointestinal stromal tumors

    Cancer Research, Vol. 73, Núm. 12, pp. 3499-3510

  3. Linfocitos CD4 como factor protector frente a la infección por genotipos oncogénicos del virus del papiloma humano en la mucosa del canal anal de varones que tienen sexo con varones infectados por el virus de la inmunodeficiencia humana

    Medicina Clinica, Vol. 140, Núm. 5, pp. 193-199

  4. MECHANISMS FOR LOSS OF BETA2-MICROGLOBULIN IN CRC IN COLON CANCER WITH MICROSATELLITE INSTABILITY

    TISSUE ANTIGENS

2012

  1. Biomedical application of fuzzy association rules for identifying breast cancer biomarkers

    Medical and Biological Engineering and Computing, Vol. 50, Núm. 9, pp. 981-990

  2. Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 6, pp. 803-816

  3. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A National Consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)

    Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 338-349

  4. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 9, pp. 1359-1371

  5. Leiomioma de esófago tratamiento por abordaje mínimamente invasivo (laparoscopia-toracoscopia)

    Cirugia Espanola

  6. MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

    Journal of Translational Medicine, Vol. 10, Núm. 1